|
ATP5F1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.16780038364561E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.31739993650626E-10 |
| Normal-vs-Stage2 |
5.252400E-01 |
| Normal-vs-Stage3 |
3.74269504277436E-11 |
| Normal-vs-Stage4 |
3.82627263206814E-12 |
| Stage1-vs-Stage2 |
2.955800E-03 |
| Stage1-vs-Stage3 |
8.177600E-02 |
| Stage1-vs-Stage4 |
5.402100E-03 |
| Stage2-vs-Stage3 |
3.153700E-04 |
| Stage2-vs-Stage4 |
3.96740000000451E-05 |
| Stage3-vs-Stage4 |
3.030800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.89075446807874E-12 |
| Normal-vs-AfricanAmerican |
7.419600E-04 |
| Normal-vs-Asian |
9.93220000022887E-07 |
| Caucasian-vs-AfricanAmerican |
2.841200E-01 |
| Caucasian-vs-Asian |
6.146200E-01 |
| AfricanAmerican-vs-Asian |
5.567600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.98600000281368E-08 |
| Normal-vs-Female |
3.05940051070763E-10 |
| Male-vs-Female |
8.724200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.209199962382E-09 |
| Normal-vs-Age(41-60Yrs) |
7.932600132321E-10 |
| Normal-vs-Age(61-80Yrs) |
8.30320000000384E-05 |
| Normal-vs-Age(81-100Yrs) |
2.937200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.117600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.222570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.712600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.415210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.983800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.034600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.383070E-03 |
| Classical-VS-Follicular |
8.75759999963144E-07 |
| Classical-VS-Other |
7.667200E-01 |
| Classical-VS-Normal |
4.76674255622811E-12 |
| Tall-VS-Follicular |
5.1727000460744E-10 |
| Tall-VS-Other |
6.081600E-01 |
| Tall-VS-Normal |
5.6621374255883E-15 |
| Follicular-VS-Other |
8.838500E-02 |
| Follicular-VS-Normal |
3.007400E-01 |
| Other-VS-Normal |
5.492300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.02790000026054E-07 |
| Normal-vs-N1 |
4.32986979603811E-15 |
| N0-vs-N1 |
6.05610000037338E-07 |
|
|
